Pages that link to "Q40209753"
Jump to navigation
Jump to search
The following pages link to Gene signature combinations improve prognostic stratification of multiple myeloma patients. (Q40209753):
Displaying 11 items.
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group (Q37037265) (← links)
- High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges (Q38979403) (← links)
- Gene Expression Profiles in Myeloma: Ready for the Real World? (Q43847809) (← links)
- EBV-associated primary nodal T/NK-cell lymphoma shows distinct molecular signature and copy number changes. (Q47447684) (← links)
- The multiple myelomas - current concepts in cytogenetic classification and therapy. (Q52717229) (← links)
- MCL1 gene co-expression module stratifies multiple myeloma and predicts response to proteasome inhibitor-based therapy. (Q53071291) (← links)
- [Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients] (Q88739454) (← links)
- Potential Clinical Application of Genomics in Multiple Myeloma (Q89066166) (← links)
- Treatment approach for young, fit, newly diagnosed multiple myeloma patients (Q90029035) (← links)
- A Network Analysis of Multiple Myeloma Related Gene Signatures (Q90384099) (← links)
- Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial (Q93050604) (← links)